MALAT1 and severe combined immunodeficiency: To validate whether MALAT1 combined with HULC promotes liver cancer stem cell growth in vivo, the stable liver cancer stem cells lines with altered expression of HULC or MALAT1 were injected subcutaneously into Balb/C (severe combined immunodeficiency) mice.